Top Markets
#1 Cortex Cortex +173.86%
#2 GEKKO GEKKO +51.79%
#3 Audiera Audiera +22.10%
#4 Pons Pons +17.28%
#5 ADO Protocol ADO Protocol +17.26%
#6 TENDIES TENDIES +16.07%
#7 Ontology Gas Ontology Gas +14.07%
#8 o1.exchange o1.exchange +13.03%
#9 Helium Helium +12.67%
#10 Siren Siren +12.60%
Coin of the day
Cortex Cortex
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classement en actions #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prix de l'action
$59.98
Dernière synchronisation: 2024-12-13
Capitalisation boursière
$1.22B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Longboard Pharmaceuticals, Inc. (LBPH)

Catégorie

Healthcare
EPS pour Longboard Pharmaceuticals, Inc. (LBPH)
EPS au September 2024 TTM : $-2.24
Selon les derniers rapports financiers et le cours de l'action de Longboard Pharmaceuticals, Inc., l’EPS actuel de la société (TTM) est de $-2.24. À la fin de 2022, la société avait un EPS de $-2.51 une augmentation par rapport à celui de 2021, qui était de $-1.62.
Historique de l'EPS de Longboard Pharmaceuticals, Inc. de 2020 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -873.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,338.39%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 136.16%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 256.25%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH